MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

Phase 2
Completed
Conditions
Non-Hodgkin's Lymphoma
Allogeneic Marrow Transplant
Leukemia
Myelodysplastic Syndrome
Interventions
Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
First Posted Date
2007-12-28
Last Posted Date
2016-02-01
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
96
Registration Number
NCT00582933
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Completed
Conditions
Breast Cancer
Lobular Carcinoma
Invasive Breast Cancer
Interventions
Other: Tissue specimen
First Posted Date
2007-12-28
Last Posted Date
2021-07-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
550
Registration Number
NCT00581750
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors

Active, not recruiting
Conditions
Head and Neck Cancer
Interventions
Radiation: DCE-MRI, DW-MRI and MRS
First Posted Date
2007-12-28
Last Posted Date
2024-03-05
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
272
Registration Number
NCT00581906
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Phase 1
Completed
Conditions
Osseous Lesions From Metastatic Breast Cancer
First Posted Date
2007-12-28
Last Posted Date
2015-12-24
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
10
Registration Number
NCT00582920
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer

Completed
Conditions
Nonmuscle Invasive Bladder Cancer
Urinary Cancer
Bladder Cancer
Interventions
Genetic: specimen samples
Behavioral: questionnaires
First Posted Date
2007-12-28
Last Posted Date
2015-12-18
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
116
Registration Number
NCT00582387
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Spectroscopy With Surface Coils and Decoupling

Phase 1
Completed
Conditions
Adrenal Cortical Cancer
Hodgkin's Disease
Ovarian Cancer
Breast Cancer
Kaposi's Sarcoma
Lung Cancer
Renal Cancer
Sarcoma
Colon Cancer
Rectal Cancer
Interventions
Device: Proton-decoupled 31P MRS at 1.5T
Device: 1H Spectroscopy at 1.5T and 3T
First Posted Date
2007-12-28
Last Posted Date
2015-12-28
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
582
Registration Number
NCT00581815
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Identification of New Colorectal Cancer Genes

Completed
Conditions
Colorectal Cancer
First Posted Date
2007-12-28
Last Posted Date
2021-12-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
337
Registration Number
NCT00582335
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients

Completed
Conditions
Colorectal Cancer
Interventions
Other: Telephone survey
First Posted Date
2007-12-28
Last Posted Date
2009-12-10
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
16
Registration Number
NCT00582452
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Men Undergoing Radical Prostatectomy

Completed
Conditions
Prostate Cancer
Interventions
Other: Whole Blood Draw
First Posted Date
2007-12-28
Last Posted Date
2022-06-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
513
Registration Number
NCT00582530
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma

Completed
Conditions
Indolent Non-Hodgkin's Lymphoma
First Posted Date
2007-12-28
Last Posted Date
2023-09-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
56
Registration Number
NCT00582270
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath